| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |